Global Regenerative Medicine Strategic Market Report 2023-2030 - Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field

PR Newswire
Wednesday, February 8, 2023 at 4:10pm UTC

Global Regenerative Medicine Strategic Market Report 2023-2030 - Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field

PR Newswire

DUBLIN, Feb. 8, 2023 /PRNewswire/ -- The "Regenerative Medicine - Global Strategic Business Report" report has been added to's offering.


Global Regenerative Medicine Market to Reach $30.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030.

Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR

The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Looking Ahead to 2023

Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Key Metrics

Report Attribute


No. of Pages


Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$9.6 Billion

Forecasted Market Value (USD) by 2030

$30.8 Billion

Compound Annual Growth Rate

15.7 %

Regions Covered



Key Topics Covered:


  • Influencer Market Insights
  • World Market Trajectories
  • Regenerative Medicine: A Preface
  • Recent Market Activity
  • An Overview of Regenerative Medicine in Bone and Joint Applications
  • Current and Future Analysis
  • Developed Markets Dominate, Developing to Drive Growth
  • Regenerative Medicine - Past, Present & Future
  • Another Revolution in the Making?
  • Conventional Chemical Medicine Vs Regenerative Medicine
  • Regenerative Medicine - Bypassing the Ethical Concerns
  • Regenerative Medicine Throws Up Several New Therapies
  • Current Global Market for Regenerative Medicine
  • Market Potential
  • Therapeutic Companies and Products in Regenerative Medicine - Current Status
  • Regenerative Medicine - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession


  • A Combination of Factors to Drive Regenerative Medicine Market
  • Burgeoning Global Population Offers Significant Growth Opportunities
  • Aging Global Population: Need for New Effective Treatments
  • Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
  • Government Support and Increased Private Sector Participation
  • Investment and Funding Landscape
  • Major M&A Activity and Strategic Alliances in Regenerative Medicine: 2011-2016
  • Recent Advancements in the Science of Regenerative Medicine
  • Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field
  • 3D Organ & Tissue Printing: Still in Early Stages
  • Nanotechnology in Regenerative Medicine
  • Issues to be Sorted Out
  • Need for New Scientific and Technological Standards
  • Standardized Guidelines
  • Clinical Translation - Collaboration of Multidisciplinary Skills is Essential
  • The Question of Apt Business Models - The Service and Product Approach
  • Autologous or Service Approach Preferred by European Firms
  • Allogenic or Product Approach - Slow to Develop
  • Regenerative Medicine Requires Improved Biomaterials
  • Investors Wary of Funding Regenerative Medicine
  • Regenerative Medicine Field Lags Behind Due to Segregated Focus
  • Challenges Encountered by Regenerative Medicine
  • Scientific and Technological Challenges
  • Barriers in Sharing Intellectual Property Rights
  • Viable Manufacturing Technologies and Skilled Personnel Crucial
  • Strict Regulations Push up Operational Costs
  • Challenges Facing Autologous Cell Therapies

FOCUS ON SELECT PLAYERS  (Total 52 Featured)

  • AlloSource (US)
  • Anika Therapeutics, Inc. (US)
  • Bioventus LLC (US)
  • DePuy Synthes Companies (US)
  • DePuy Synthes Spine, Inc. (US)
  • Exactech, Inc. (US)
  • Integra LifeSciences Holdings Corp. (US)
  • LifeNet Health, Inc. (US)
  • Medtronic, plc (Ireland)
  • NovaBone Products LLC (US)
  • NuVasive, Inc. (US)
  • Orthofix International N.V. (Netherlands)
  • Osiris Therapeutics, Inc. (US)
  • Smith & Nephew plc (UK)
  • Stryker Corporation (US)
  • Wright Medical Technology, Inc. (US)
  • Zimmer Biomet Holdings, Inc. (US)

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 


Cision View original content:

SOURCE Research and Markets